Redefining proteomics at HUPO 2025

At HUPO 2025 in Toronto Canada, we're excited to share how our novel method for complete proteome analysis, Iterative Mapping, is redefining proteomics and is designed to robustly quantify the full proteome including its many proteoforms. Drop by our booth, lunch seminar, posters, and presentation to learn how you can use Iterative Mapping in your work and participate in our scavenger hunt for your chance to win a Nintendo® Switch 2^TM!

Making proteoforms mainstream at CTDP

In August, we had the privilege of attending the Consortium for Top-Down Proteomics (CTDP) where we met with leaders in the top-down community to confront problems with the perception and adoption of proteoform-centric research. Key takeaways from the conference can be found in the blog post below. We look forward to working with members of this community to revolutionize biology and usher in a new era of proteoform-powered precision medicine.

Nautilus signs agreement with Allen Institute

We recently announced that we've entered into an agreement with the Allen Institute focused on investigating the connection between the tau protein and neurodegenerative conditions such as Alzheimer's. This agreement further validates the importance and potential of novel single-molecule proteomic data like that shared in our recent preprint. In the post below, find articles discussing this agreement and further excitement surrounding Iterative Mapping's potential to redefine proteomics.

Watch our latest investor presentation

In our latest investor presentation, Nautilus CEO Sujal Patel and Nautilus CFO Anna Mowry share why the world needs the Nautilus Platform, why other proteomics platforms aren't up to the task of quantifying the proteome, and how Iterative Mapping represents a complete solution to the problem of comprehensive proteome analysis. View the presentation for a succinct look at the story of Nautilus and how we plan to bring our platform to the market.

Subscribe to the Nautilus Blog